Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

v3.23.1
Accrued Expenses and Other Current Liabilities
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

9. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Vaxcyte-related accrual under Vaxcyte Supply Agreement

 

$

4,830

 

 

$

2,286

 

CMO-related accrual

 

 

3,900

 

 

 

1,102

 

Clinical trials-related accrual

 

 

2,954

 

 

 

2,264

 

Other

 

 

3,080

 

 

 

2,750

 

Total accrued expenses and other current liabilities

 

$

14,764

 

 

$

8,402